Network-1 Sec Solu (NTIP)

Dec 26, 2024, 8:30 AM EST - 22 days ago

Network-1 Commences Patent Litigation against Citadel Securities and Jump Trading

Dec 11, 2024, 12:30 PM EST - 5 weeks ago

Network-1 Receives New Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 55 Patents Worldwide

Oct 24, 2024, 4:30 PM EDT - 3 months ago

Network-1 Reports Third Quarter Results

Oct 8, 2024, 12:07 PM EDT - 3 months ago

Network-1 Subsidiary Receives New Patent from U.S. Patent Office Expanding Its HFT Patent Portfolio To Include 11 Issued U.S. Patents

Oct 1, 2024, 1:17 PM EDT - 3 months ago

Network-1 Subsidiary Receives New Patent from U.S. Patent Office Expanding Its HFT Patent Portfolio to Include 10 Issued U.S. Patents

Aug 27, 2024, 2:00 PM EDT - 5 months ago

Network-1 Declares Semi-Annual Dividend

Aug 12, 2024, 4:30 PM EDT - 5 months ago

Network-1 Reports Second Quarter Results

May 10, 2024, 4:30 PM EDT - 9 months ago

Network-1 Reports First Quarter 2024 Results

Mar 8, 2024, 5:00 PM EST - 11 months ago

Network-1 Reports 2023 Year-End Financial Results

Mar 1, 2024, 8:45 AM EST - 11 months ago

Network-1 Receives New Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 51 Patents Worldwide

Sep 6, 2023, 8:30 AM EDT - 1 year ago

ILiAD Biotechnologies Reports First-ever Demonstration of Protection Against B. pertussis Colonization in Phase 2b Human Challenge Study of BPZE1 Vaccine

Aug 28, 2023, 8:30 AM EDT - 1 year ago

Network-1 Receives New eSIM Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 50 Patents Worldwide

Jun 14, 2023, 4:30 PM EDT - 1 year ago

Network-1 Extends its Share Repurchase Program

May 12, 2023, 4:30 PM EDT - 1 year ago

Network-1 Reports First Quarter 2023 Results

Mar 30, 2023, 4:30 PM EDT - 1 year ago

Network-1 Reports 2022 Year-End Financial Results

Feb 13, 2023, 10:00 AM EST - 2 years ago

Network-1 Subsidiary Receives New Patent from U.S. Patent Office Expanding its HFT Patent Portfolio to Include 9 Issued U.S. Patents

Aug 15, 2022, 9:50 PM EDT - 2 years ago

CORRECTION: Network-1 Reports Second Quarter Results

May 16, 2022, 5:00 PM EDT - 2 years ago

Network-1 Reports First Quarter 2022 Results

May 13, 2022, 9:00 AM EDT - 2 years ago

Network-1 Subsidiary Receives New Patent from U.S. Patent Office Expanding Its HFT Patent Portfolio To Include 7 Issued U.S. Patents

Apr 30, 2022, 11:10 AM EDT - 2 years ago

Network-1 Technologies: Selling At Cash Liquidation Value With Building Technical Momentum

Mar 30, 2022, 5:00 PM EDT - 3 years ago

Network-1 Reports 2021 Year-End Financial Results

Mar 28, 2022, 2:00 PM EDT - 3 years ago

Network-1 Announces Acquisition of High Frequency Trading Patent Portfolio

Aug 17, 2021, 9:50 AM EDT - 3 years ago

5 Undervalued Stocks In The Tech Sector

QIWI WYY

Aug 9, 2021, 1:00 PM EDT - 3 years ago

Network-1 Receives New Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio To Include 30 Issued U.S. Patents

Jul 29, 2021, 3:35 PM EDT - 3 years ago

Network-1 Technologies: Back To Net Cash

Jul 27, 2021, 2:34 PM EDT - 3 years ago

Network-1 Settles Patent Lawsuit With Hewlett Packard For $17M

HPE HPQ

Jul 27, 2021, 1:30 PM EDT - 3 years ago

Network-1 Announces Settlement of Patent Litigation With Hewlett Packard

Jul 14, 2021, 3:00 PM EDT - 3 years ago

Network-1 Expands Its Foreign M2M/IoT Patent Portfolio With Three New Granted Patents

May 17, 2021, 4:30 PM EDT - 3 years ago

Network-1 Reports First Quarter 2021 Results

Mar 31, 2021, 4:30 PM EDT - 4 years ago

Network-1 Reports 2020 Year-End Financial Results

Oct 31, 2020, 3:32 PM EDT - 4 years ago

The Market Is Dramatically Undervaluing Network-1 Technologies

Sep 28, 2020, 11:20 AM EDT - 4 years ago

Network-1 Technologies: Free Call Options In A Cash-Rich Public Company

Mar 19, 2020, 1:17 PM EDT - 5 years ago

2 Stocks With Strong Balance Sheets And Virus Resistant Business Models

FONR

Jun 11, 2019, 10:32 AM EDT - 6 years ago

Network 1 - A Sum Of Parts Value Opportunity

Apr 22, 2019, 2:35 PM EDT - 6 years ago

Evaluating Network-1 Technologies' Biotech Investment